comparemela.com

Director Bridgette News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Azimuth Capital Investment Management LLC Buys Shares of 55,633 DexCom, Inc (NASDAQ:DXCM)

Azimuth Capital Investment Management LLC Buys Shares of 55,633 DexCom, Inc (NASDAQ:DXCM)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Azimuth Capital Investment Management LLC Buys Shares of 55,633 DexCom, Inc (NASDAQ:DXCM)

Azimuth Capital Investment Management LLC Buys Shares of 55,633 DexCom, Inc (NASDAQ:DXCM)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

1,853 Shares in DexCom, Inc (NASDAQ:DXCM) Bought by Perigon Wealth Management LLC

Perigon Wealth Management LLC bought a new position in DexCom, Inc. (NASDAQ:DXCM – Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 1,853 shares of the medical device company’s stock, valued at approximately $238,000. Other hedge funds and other institutional […]

NorthRock Partners LLC Sells 335 Shares of DexCom, Inc (NASDAQ:DXCM)

NorthRock Partners LLC decreased its stake in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 9.5% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,203 shares of the medical device company’s stock after selling 335 shares during the quarter. NorthRock Partners […]

DexCom (NASDAQ:DXCM) Given New $100 00 Price Target at JPMorgan Chase & Co

DexCom (NASDAQ:DXCM – Free Report) had its price objective decreased by JPMorgan Chase & Co. from $160.00 to $100.00 in a report issued on Tuesday morning, Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the medical device company’s stock. Several other equities research analysts have also issued reports on the company. […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.